The October 2022 workshop provided a forum for Australia’s leading cancer researchers, CCTGs, and the GCCTI Scientific Steering Group and Project Team to focus on topics and generate ideas for future research. This workshop sessions included:
- Grants updates from MRFF and Cancer Australia
- Statistical sharing and borrowing in clinical trials
- Microbiome and molecularly targeted cancer treatment
- ctDNA guiding treatment of multiple cancer types.
Workshop Downloads
Presentations
- Overview of GCCTI and working with GCCTI (Martin Stockler)
- Grants update: what’s new and helpful for grant-writers
- Statistical sharing and borrowing in clinical trials
- Microbiome and molecularly targeted cancer treatment
- Harnessing the power of the microbiome in the cancer field (Emad El-Omar)
- Neoadjuvant immunotherapy, the gut microbiome and circulating immune subsets: implications for efficacy and toxicity (Georgina Long and Rebecca Simpson)
- Harnessing the microbiome – potential targets and multicancer trials (Katrin Sjoquist)
- ctDNA guiding treatment of multiple cancer types
- ctDNA guiding adjuvant chemotherapy in early stage colon cancer: are we moving the needle? (Jeanne Tie)
- ctDNA captures distinct clonal dynamics following alternative osimertinib and gefitinib therapy in advanced EGFR T790M positive non-small cell lung cancer: result from the OSCILLATE trial (Lavinia Tan)
- Incorporating ctDNA studies in cancer trials (Sonia Yip)
Workshop Report
The workshop report includes a summary of presentations and discussion from the day, including the workshop evaluation. It can be accessed from the link below.